One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially leaving patients, healthcare providers and insurers scrambling.

The change comes as a result of a federal ban on CFC (chlorofluorocarbons) albuterol inhalers that goes into effect Dec. 31, 2008. "Before, I felt like the medication worked but that most of it ended ...

WASHINGTON —The Food and Drug Administration at the end of May issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane-propelled ...

A popular corticosteroid inhaler used to treat asthma and other conditions is being discontinued, and despite generic versions now available, health experts are warning patients to plan ahead for ...

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

WASHINGTON (Reuters) - U.S. patients who use certain asthma inhalers made with ozone-depleting propellants should talk to their doctors now about alternatives ahead of a ban that starts in January, ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the first generic of ProAir HFA inhalation aerosol — albuterol sulfate — for the treatment ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

Starting January 1, a drug that thousands of patients depend on to help them breathe will disappear from pharmacy shelves, and doctors are concerned patients may have delays switching to alternatives ...

Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai BENGALURU (Reuters) -Indian drugmaker Cipla said on Friday its U.S. unit was recalling six batches of ...